Knowing this, we examined how patients actually respond to GLP-1s amidst their unique daily challenges and routines, and needless to say, we learned a lot
Understanding your genetic predispositions in GLP-1R, GIPR, and metabolic pathways can support a personalized discussion with your healthcare provider about which receptor-targeting strategytriple-agonist, dual-agonist, or monoagonistmay be most appropriate for your metabolic profile, weight management goals, and risk tolerance
Data from other continents could have provided us with a broader understanding of geographical differences, which may be related to varied genetic backgrounds
Naltrexone/Bupropion ER (Contrave): Trials, Dosing, Safety
Another theory is that semaglutide, which belongs to a group of medications called GLP-1 receptor agonists, may cause nausea by activating GLP-1 receptors in the brain, which helps control appetite and blood sugar levels